Regenxbio (RGNX) Net Margin (2014 - 2025)
Regenxbio (RGNX) recorded quarterly Net Margin of 221.4% in Q4 2025, down 6.25% quarter-over-quarter from 208.39% in Q3 2025, and up 2027.0% on a YoY basis from 10.41% in Q4 2024.
Regenxbio (RGNX) Net Margin (2014 - 2025) Analysis & Trends
Regenxbio's Net Margin history runs 12 years deep, the most recent figure standing at 221.4% for Q4 2025.
- In Q4 2025, Net Margin rose 2027.0% year-over-year to 221.4%; the TTM figure through Dec 2025 stood at 113.8% (up 15895.0% YoY), while the FY2025 annual figure was 113.8%, up 15874.0% from the prior year.
- Net Margin was 221.4% for Q4 2025 at Regenxbio, down from 208.39% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 703.16% in Q4 2022 to a low of 405.63% in Q1 2024.
- Historically, Net Margin has averaged 193.59% across 5 years, with a median of 244.04% in 2024.
- The sharpest annual moves came in 2022 and 2023: Net Margin jumped 62941 bps in 2022, then tumbled 98664 bps in 2023.
- A 5-year view of Net Margin shows it stood at 73.75% in 2021, then soared by 853 bps to 703.16% in 2022, then slumped by 140 bps to 283.48% in 2023, then climbed by 15 bps to 241.68% in 2024, then climbed by 8 bps to 221.4% in 2025.
- The last three Net Margin figures came in at 221.4% (Q4 2025), 208.39% (Q3 2025), and 331.91% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.82% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | -221.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -221.40% |
| Sep 30, 2025 | -208.39% |
| Jun 30, 2025 | -331.91% |
| Mar 31, 2025 | 6.81% |
| Dec 31, 2024 | -241.68% |
| Sep 30, 2024 | -246.40% |
| Jun 30, 2024 | -237.80% |
| Mar 31, 2024 | -405.63% |
| Dec 31, 2023 | -283.48% |
| Sep 30, 2023 | -213.97% |
| Jun 30, 2023 | -360.72% |
| Mar 31, 2023 | -348.40% |
| Dec 31, 2022 | 703.16% |
| Sep 30, 2022 | -284.72% |
| Jun 30, 2022 | -208.82% |
| Mar 31, 2022 | -345.32% |
| Dec 31, 2021 | 73.75% |
| Sep 30, 2021 | -189.79% |
| Jun 30, 2021 | -261.58% |
| Mar 31, 2021 | -265.51% |